抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
盐酸多佐胺 | dorzolamide hydrochloride | 130693-82-2 | C10H16N2O4S3*ClH |
|
盐酸地托咪定 | detomidine hydrochloride | 90038-01-0 | C12H14N2*ClH |
|
盐酸右美托咪定 | dexmedetomidine hydrochloride | —— | C13H16N2*ClH |
|
盐酸伊伐布雷定 | ivabradine hydrochloride | 148849-67-6 | C27H36N2O5*ClH |
|
盐酸二苯美伦 | 2-(4-Methylaminobutoxy)diphenylmethane hydrochloride | 62232-46-6 | C18H23NO*ClH |
|
白血病孤儿药 | vosaroxin | 175414-77-4 | C18H19N5O4S |
|
甲磺酸雷沙吉兰 | rasagiline mesylate | 161735-79-1 | CH4O3S*C12H13N |
|
甲磺酸萘莫司他 | nafamostat mesylate | 82956-11-4 | CH4O3S*C19H17N5O2 |
|
甲磺酸奈非那韦 | nelfinavir mesylate | 159989-65-8 | CH4O3S*C32H45N3O4S |
|
甲磺酸培高利特 | pergolide mesylate | 66104-23-2 | CH4O3S*C19H26N2S |
|
甲磺酸卡莫司他 | camostat mesylate | 59721-29-8 | CH4O3S*C20H22N4O5 |
|
甲磺酸依普罗沙坦 | eprosartan mesylate | 144143-96-4 | CH4O3S*C23H24N2O4S |
|
甲硫二苯马尼 | diphemanil methylsulfate | 62-97-5 | CH3O4S*C20H24N |
|
甲基巴多索隆 | bardoxolone methyl | 218600-53-4 | C32H43NO4 |
|
甲基0328 | 3,4-dihydro-4-oxo-N-[(1S)-1-phenylethyl]-2-quinazolinepropanamide | 1445251-22-8 | C19H19N3O2 |
|
甘氨酰精氨酰甘氨酰-alpha-天冬氨酰-D-丝氨酰脯氨酸 | GRGDdSP | 91037-75-1 | C22H37N9O10 |
|
瓦他拉尼二盐酸盐 | Vatalanib dihydrochloride | 212141-51-0 | C20H17Cl3N4 |
|
瑞法替尼 | Refametinib | 923032-37-5 | C19H20F3IN2O5S |
|
瑞卡帕布(AG-014699) | AG-014699 | 459868-92-9 | C19H18FN3O*H3O4P |
|
瑞博司可里布 | ribociclib | 1211441-98-3 | C23H30N8O |
|
琥珀酸索利那辛 | solifenacin succinate | 242478-38-2 | C4H6O4*C23H26N2O2 |
|
琥珀酸去甲文拉法辛 | desvenlafaxine succinate monohydrate | 386750-22-7 | C4H6O4*C16H25NO2*H2O |
|
玻玛西林 | SRT2104 | 1093403-33-8 | C26H24N6O2S2 |
|
环维黄杨星D | DBZ | 209984-56-5 | C26H23F2N3O3 |
|
环磷酰胺一水合物 | cyclophosphamide | 6055-19-2 | C7H15Cl2N2O2P*H2O |
|
环磷酰胺 | cyclophosphamide | 50-18-0 | C7H15Cl2N2O2P |
|
环状抑制剂-α氢溴酸盐 | cyclic pifithrin-α | 511296-88-1 | BrH*C16H16N2S |
|
环戊丙酸雌二醇 | estradiol 17β-cypionate | 313-06-4 | C26H36O3 |
|
环巴胺抑制剂1 | 6-(imidazo[1,2-a]pyridin-3-yl)-N-(piperidin-4-yl)pyridin-2-amine | 1042224-63-4 | C17H19N5 |
|
环巴胺 | cyclopamine | 4449-51-8 | C27H41NO2 |
|
环孢霉素A | SangCyA | 79217-60-0 | C62H111N11O12 |
|
环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯 | ciproxifan | 184025-18-1 | C16H18N2O2 |
|
玛伐凯泰 | mavacamten | 1642288-47-8 | C15H19N3O2 |
|
猴子补体蛋白4(C4)ELISA试剂盒 | isopropyl 3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-glucopyranoside | 40592-88-9 | C17H27NO9 |
|
特立氟胺 | teriflunomide | 163451-81-8 | C12H9F3N2O2 |
|
特拉匹韦 | (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide | 402957-28-2 | C36H53N7O6 |
|
牛奶树碱 | hispidin | 555-55-5 | C13H10O5 |
|
灭瘟素S盐酸盐 | blasticidin S hydrochloride | 3513-03-9 | C17H26N8O5*ClH |
|
潮霉素 A | hygromycin A | 6379-56-2 | C23H29NO12 |
|
溴芬酸钠 | 91714-93-1 | C15H12BrNNaO3 |
|
|
浅黄色至白色固体 | 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acid | 1359963-68-0 | C19H25N3O4 |
|
洛那法尼 | lonafarnib | 193275-84-2 | C27H31Br2ClN4O2 |
|
泽布替尼 | zanubrutinib | 1691249-45-2 | C27H29N5O3 |
|
泰妥拉唑 | tenatoprazole | 113712-98-4 | C16H18N4O3S |
|
波齐替尼 | poziotinib | 1092364-38-9 | C23H21Cl2FN4O3 |
|
波生坦(水合物) | bosentan monohydrate | 157212-55-0 | C27H29N5O6S*H2O |
|
波生坦 | bosentan | 147536-97-8 | C27H29N5O6S |
|
泛EGFR小分子抑制剂(VARLITINIB) | Varlitinib | 845272-21-1 | C22H19ClN6O2S |
|
法硼巴坦 | vaborbactam | 1360457-46-0 | C12H16BNO5S |
|
法尼基硫代水杨酸 | salirasib | 162520-00-5 | C22H30O2S |
|